trending Market Intelligence /marketintelligence/en/news-insights/trending/v2o27tlpfgecwuk6errugg2 content esgSubNav
In This List

Edwards Lifesciences to issue $600M of senior notes

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Edwards Lifesciences to issue $600M of senior notes

Edwards Lifesciences Corp. will issue $600 million of 4.300% senior unsecured notes due 2028.

The Irvine, Calif.-based medical device maker said it expects net proceeds of $594.7 million from the offering.

Merrill Lynch Pierce Fenner & Smith Inc., J.P. Morgan Securities LLC, Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities LLC are serving as joint book-running managers.